Abstract
Intravenous inoculation of a penicillin-resistant, phage type 80/81 staphylococcus caused lethal infection in six of eight untreated monkeys. Daily intragastric administration of clindamycin hydrochloride and erythromycin stearate and intramuscular inoculation of clindamycin-2-phosphate and methicillin, all at a dose level of 50 mg/kg, was followed by mortalities of one of eight, one of eight, none of eight, and one of eight monkeys, respectively. Duration of obvious acute illness in surviving monkeys and time required for complete recovery were not significantly different in the four therapy groups with the exception that duration of acute illness in monkeys treated with clindamycin-2-phosphate (mean, 4.1 days) was significantly shorter than in monkeys given erythromycin stearate (mean, 7.1 days). In vitro sensitivity data and serum antibacterial levels would suggest that methicillin would be the least effective therapeutically, followed by erythromycin stearate and the two clindamycin preparations in that order. However, this prediction was not fulfilled in these studies in experimentally infected monkeys.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Magerlein B. J., Birkenmeyer R. D., Kagan F. Chemical modification of lincomycin. Antimicrob Agents Chemother (Bethesda) 1966;6:727–736. [PubMed] [Google Scholar]
- McGehee R. F., Jr, Smith C. B., Wilcox C., Finland M. Comparative studies of antibacterial activity in vitro and absorption and excretion of lincomycin and clinimycin. Am J Med Sci. 1968 Nov;256(5):279–292. doi: 10.1097/00000441-196811000-00002. [DOI] [PubMed] [Google Scholar]
- Perkins R. L., Carlisle H. N., Saslaw S. Cephalexin: in vitro bacterial susceptibility, absorption in volunteers, and antibacterial activity of sera and urine. Am J Med Sci. 1968 Aug;256(2):122–129. [PubMed] [Google Scholar]
- Saslaw S., Carlisle H. N. Comparison of cephalexin, penicillin V, and ampicillin in streptococcal infections in monkeys. Appl Microbiol. 1970 Jun;19(6):943–949. doi: 10.1128/am.19.6.943-949.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Saslaw S., Carlisle H. N. Comparison of cephalothin, cephaloridine, cephalexin and cephaloglycin in streptococcal infections in monkeys. Am J Med Sci. 1969 Jun;257(6):395–407. doi: 10.1097/00000441-196906000-00006. [DOI] [PubMed] [Google Scholar]
- Saslaw S., Carlisle H. N., Marietti M. Therapy of staphylococcal infections in monkeys. IV. Further comparison of triacetyloleandomycin and erythromycins. Appl Microbiol. 1969 Dec;18(6):1077–1083. doi: 10.1128/am.18.6.1077-1083.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Saslaw S., Carlisle H. N., Sparks J. Studies on therapy of staphylococcal infections in monkeys. V. Comparison of cephalexin, oxacillin, cloxacillin, dicloxacillin and nafcillin. Am J Med Sci. 1970 Feb;259(2):143–152. doi: 10.1097/00000441-197002000-00008. [DOI] [PubMed] [Google Scholar]
- Saslaw S., Carlisle H. N. Staphylococcal infection in normal and splenectomized monkeys. Proc Soc Exp Biol Med. 1966 Nov;123(2):565–571. doi: 10.3181/00379727-123-31544. [DOI] [PubMed] [Google Scholar]
- Saslaw S., Carlisle H. N. Studies of therapy of staphylococcal infections in monkeys. II. Comparison of cloxacillin, dicloxacillin, and leucomycin. Proc Soc Exp Biol Med. 1968 Jun;128(2):358–363. doi: 10.3181/00379727-128-33014. [DOI] [PubMed] [Google Scholar]
- Saslaw S., Carlisle H. N. Studies on therapy of staphylococcal infections in monkeys. 3. Comparison of cephalothin, cephaloridine and cephalexin. Am J Med Sci. 1968 Sep;256(3):136–149. doi: 10.1097/00000441-196809000-00002. [DOI] [PubMed] [Google Scholar]
- Saslaw S., Carlisle H. N. Studies on therapy of staphylococcal infections in monkeys. I. Comparison of cloxacillin, triacetyloleandomycin and erythromycin. Proc Soc Exp Biol Med. 1967 Aug-Sep;125(4):1168–1173. doi: 10.3181/00379727-125-32304. [DOI] [PubMed] [Google Scholar]